Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Trelstar clinical trials
2 selected ClinicalTrials.gov records carrying the official matched intervention Trelstar (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
2 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 30 selected PubMed records and 4 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT01467882
PeptideScanner retained ClinicalTrials.gov record NCT01467882 at 2026-11-15T21:49:16.513Z. Its registry update date was 2017-07-28, and PeptideScanner's reviewed identity mapping was triptorelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- July 28, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06513962
PeptideScanner retained ClinicalTrials.gov record NCT06513962 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was triptorelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- August 31, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Triptorelin · 2026-08-31
ClinicalTrials.gov record NCT06513962
Recruiting at the retained observation.
Open attributed record →Triptorelin · 2017-07-28
ClinicalTrials.gov record NCT01467882
Completed at the retained observation.
Open attributed record →